{"resourceType": "Evidence", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparator-only-evidence"], "versionId": "60", "lastUpdated": "2024-10-03T13:11:20.368Z"}, "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net", "value": "236958", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "outcomeId"}, "system": "https://app.magicapp.org/#/guidelines", "value": "313957"}, {"type": {"text": "picoId"}, "system": "https://app.magicapp.org/#/guidelines", "value": "85798"}, {"type": {"text": "sectionId"}, "system": "https://app.magicapp.org/#/guidelines", "value": "73215"}], "name": "Cardiovascular_mortalityComparator_Evidence_from_MAGICapp_313957", "title": "MAGIC-derived Evidence: Cardiovascular mortality Comparator Evidence", "status": "active", "author": [{"name": "Computable Publishing\u00ae: MAGIC-to-FEvIR Converter"}], "useContext": [{"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "ComparatorOnlyEvidence", "display": "ComparatorOnlyEvidence"}]}}], "relatedArtifact": [{"type": "part-of", "resourceReference": {"type": "Composition", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-conversion-report", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"}}], "note": [{"text": "From RECODe to an estimate per 1000 patients for 5 years with the following assumption: CV mortality is 2/3 of all-cause mortality (https://sanjaybasu.shinyapps.io/recode/)."}], "variableDefinition": [{"description": "Adults with type 2 diabetes -- GLP-1 RA", "variableRole": "population", "observed": {"type": "Group", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-comparator-group-MAGIC-5288-j1Wqrn-comparator-85394-C-85798", "assigner": {"display": "Computable Publishing LLC"}}, "display": "GLP-1 RA Group in Adults with type 2 diabetes", "reference": "Group/236948"}}, {"description": "Cardiovascular mortality", "variableRole": "outcome", "observed": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313957", "assigner": {"display": "Computable Publishing LLC"}}, "display": "Cardiovascular mortality", "reference": "EvidenceVariable/236956"}}], "synthesisType": {"text": "NOTSET"}, "studyDesign": [{"text": "NO_STUDY"}], "statistic": [{"description": "Risk 15.7%", "statisticType": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/statistic-type", "version": "5.0.0-cibuild", "code": "C44256", "display": "Proportion"}]}, "quantity": {"value": 0.157}}], "url": "https://fevir.net/resources/Evidence/236958", "id": "236958", "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."}